Taizhou Cowingene Biotech Co., Ltd.

🦠 Ebola Outbreak: The Role of Timely Molecular Detection

The Democratic Republic of the Congo is responding to an outbreak of Bundibugyo virus disease, with cases reported across multiple health zones.

According to the latest available data from Africa CDC, as of 16 August 2026, the outbreak in the DRC had recorded:

5,021 confirmed cases
2,378 deaths
6 provinces
55 health zones

In the context of infectious disease outbreaks, timely laboratory confirmation can support case management, surveillance, contact tracing, and public health response.

🔬 Cowingene Ebolavirus Detection Kit

The Cowingene Ebolavirus Detection Kit is designed for the qualitative detection of Ebolavirus nucleic acids in serum and plasma samples using real-time PCR.

The kit is designed to detect four Ebola virus species known to cause human disease:

• Zaire ebolavirus
• Sudan ebolavirus
• Bundibugyo ebolavirus
• Taï Forest ebolavirus

Key Features:

✔ Real-time PCR detection
✔ LoD: 400 copies/mL
✔ β-globin internal control for process monitoring
✔ 48 tests/kit
✔ Compatible with open real-time PCR platforms
With reliable molecular detection, laboratories can support the identification and confirmation of suspected Ebola virus infections as part of broader surveillance and outbreak response efforts.

Learn more about our molecular diagnostic solutions:
🌐 www.cowingene.com

🌍 Happy International Youth Day!

Youth is a time to dream boldly, explore new possibilities, and turn ideas into meaningful action. Every young generation brings fresh perspectives, new energy, and the courage to shape what comes next.

Today, we celebrate the passion, creativity, and potential of young people around the world. May you always have the courage to pursue your dreams, the confidence to embrace new challenges, and the determination to make a difference.

✨ Let youth shine, let dreams take flight.
Together, let’s create a future full of possibilities.

One Cartridge. One Workflow. Reliable PCR Results.

Molecular PCR testing has long been recognized for its high sensitivity and specificity. But behind every reliable PCR result is a workflow that traditionally involves multiple critical steps—from nucleic acid extraction and amplification to fluorescence detection and result interpretation.
Each additional step requires dedicated equipment, trained personnel, and standardized laboratory procedures, while also increasing hands-on time and the risk of contamination.

As molecular diagnostics continue to move beyond the central laboratory, there is a growing demand for systems that simplify this workflow without compromising PCR performance.

The NATBox® Molecular POCT System addresses this need through a fully integrated molecular PCR system powered by a patented all-in-one cartridge.
With a streamlined workflow of:
Sample In → Extraction → PCR Amplification → Detection → Result
NATBox integrates the entire molecular testing process into a closed cartridge, minimizing manual intervention while delivering reliable real-time PCR results.

The patented cartridge incorporates dedicated chambers for lysis, nucleic acid purification, and PCR reaction, enabling automated sample processing within a single consumable. The closed design also helps reduce contamination risks while simplifying laboratory operations.

Because the future of molecular diagnostics is not only about bringing testing closer to patients—it's also about making laboratory-quality PCR simpler, smarter, and more integrated.

Bringing Molecular Diagnostics Beyond the Central Laboratory

As the demand for rapid and accurate molecular diagnostics continues to grow, testing is no longer expected to remain exclusively within central laboratories.

Today, community hospitals, regional laboratories, outpatient clinics, emergency departments, and other decentralized healthcare settings are increasingly adopting molecular diagnostics to support faster clinical decision-making and expand access to high-quality testing.

This shift is reshaping the way molecular testing is delivered—from centralized laboratory services toward more accessible testing closer to patients.

Designed for this evolving landscape, the NATBox® Molecular POCT System extends laboratory-quality molecular testing beyond the central laboratory through an integrated sample-to-result workflow. It enables more healthcare facilities to perform reliable real-time PCR testing with greater flexibility and operational simplicity.
Because the future of molecular diagnostics is not about replacing central laboratories—it's about making molecular testing accessible wherever it can create greater clinical value.

NATBox®
Bringing Molecular Diagnostics Beyond the Central Laboratory.

☀️ Summer Heat, Smarter Molecular Testing

As temperatures rise during the summer months, maintaining temperature-sensitive products throughout storage and transportation becomes even more challenging.

For molecular diagnostics, cold-chain management can add complexity to logistics, inventory, and routine laboratory operations.

This is one of the reasons why lyophilized PCR reagents are becoming an increasingly attractive option.

Designed for 2–30°C storage, Cowingene's lyophilized molecular assays help provide greater flexibility across the testing workflow by:

✅ Reducing dependence on frozen storage during transportation and storage
✅ Simplifying international shipping and inventory management
✅ Supporting laboratories in regions where cold-chain infrastructure may be limited
✅ Delivering the convenience of ready-to-use reagents for routine molecular testing

Whether it's summer logistics or everyday laboratory operations, greater storage flexibility helps laboratories focus on what matters most—delivering reliable molecular diagnostic results.

Less dependence on cold-chain. More flexibility for molecular diagnostics.

🧬 One PCR Program. Two Powerful Assays.

Routine molecular testing shouldn't require multiple PCR protocols.

The Cowingene HPV 40 Genotyping Detection Kit and STI Multiplex Pro 21 Detection Kit are designed to run on the same real-time PCR amplification program, allowing laboratories to perform comprehensive HPV genotyping and STI pathogen detection with a standardized workflow.

By eliminating the need to switch PCR cycling conditions, laboratories can simplify daily operations while maintaining testing flexibility.

Why combine HPV 40 and STI 21?

🧪 Comprehensive Women's Health Testing
Detect 40 HPV genotypes alongside 21 sexually transmitted pathogens to support broader molecular testing needs.

⚙️ One PCR Program
Identical amplification conditions help standardize PCR protocols across both assays, reducing workflow complexity.

🔬 Simplified Laboratory Operations
No need to create separate amplification programs, making assay scheduling and routine testing more efficient.

📈 Improved Laboratory Efficiency
Standardized workflows help optimize instrument utilization, simplify staff training, and improve operational consistency.

One Sample. Two Molecular Insights.

Using a cervical or vaginal swab specimen, laboratories can perform HPV genotyping and STI pathogen detection through separate test reactions, supporting comprehensive molecular diagnostics while maximizing specimen utilization.

Designed for Women's Health Diagnostics

The combination of HPV 40 and STI 21 provides laboratories with a practical solution for comprehensive women's health testing—bringing together broad detection coverage with a standardized PCR workflow to improve efficiency without compromising flexibility.

One PCR Program. Two Comprehensive Assays. Greater Laboratory Efficiency.

Cowingene Molecular Diagnostics
Simplifying molecular testing through standardized workflows.

📩 Interested in optimizing your HPV and STI testing workflow?
Contact Cowingene to learn more

One Sample Two Valuable Answers

In molecular diagnostics, efficiency is more than fast turnaround time—it starts with a smarter, more standardized laboratory workflow.

The Cowingene HPV 28 Genotyping Detection Kit and Cowingene 14 Kinds of Sexually Transmitted Infection Detection Kit are designed to work seamlessly together. Both assays use the same real-time PCR amplification program, enabling laboratories to standardize PCR protocols while supporting two essential areas of women's health diagnostics.

For cervical or vaginal swab specimens, a single collected sample can be used for both HPV genotyping and STI pathogen detection (performed in separate test reactions). This approach helps maximize specimen utilization, improves patient convenience, and streamlines laboratory operations.

Why does this matter?
One Sample Collection
A single cervical or vaginal swab supports both HPV and STI molecular testing, reducing unnecessary repeat sampling.
One PCR Program
Identical amplification conditions allow both assays to run using the same thermal cycling protocol, simplifying laboratory standardization.
Simplified Laboratory Workflow
A unified PCR program minimizes protocol switching, reduces setup complexity, and helps improve day-to-day laboratory efficiency.
Higher Operational Efficiency
Standardized workflows simplify staff training, optimize instrument scheduling, and support consistent, reliable molecular testing.

Supporting Comprehensive Women's Health Testing
HPV infection and Sexually transmitted infections frequently coexist and may be assessed during the same clinical visit. By combining one specimen collection with a standardized PCR workflow, laboratories can deliver more comprehensive molecular testing while maintaining operational simplicity and efficiency.

Contact Cowingene to learn more about our comprehensive HPV and STI molecular diagnostics portfolio.

Early Detection Starts with Comprehensive STI Screening

Sexually transmitted infections (STIs) remain a major global public health challenge. According to the World Health Organization (WHO), strengthening screening and timely diagnosis is essential to reducing the burden of STIs, particularly as many infections can remain asymptomatic and therefore go undetected. WHO's Global Health Sector Strategies on HIV, Viral Hepatitis and STIs also set an ambitious target of reducing new syphilis and gonorrhea infections by 90% by 2030 through improved prevention, testing, and treatment services.

Comprehensive laboratory testing plays a vital role in achieving these goals. Molecular diagnostics enable accurate detection of multiple STI pathogens, supporting earlier diagnosis, timely treatment, and more effective patient management.

At Cowingene, we provide flexible molecular diagnostic solutions to support diverse STI testing needs:

Cowingene 14 Kinds of Sexually Transmitted Infection Detection Kit
Simultaneous detection of 14 clinically relevant STI pathogens in a single assay
Covers bacterial, viral, fungal, and protozoal pathogens associated with sexually transmitted infections
Supports comprehensive routine STI screening with improved laboratory efficiency

Cowingene STI Multiplex Pro Detection Kit
A modular molecular diagnostic portfolio designed for comprehensive STI testing
Offers multiple assay options, including STI Essential Assay, Ge***al Ulcer Assay, and Candidiasis Assay
Enables laboratories to select the most appropriate testing solution based on different clinical and diagnostic requirements

By expanding pathogen coverage while maintaining testing flexibility, Cowingene helps laboratories improve diagnostic efficiency and supports more informed clinical decision-making in STI management.

Contact us to learn more about our comprehensive STI molecular diagnostic solutions.

Extended HPV Genotyping in Risk-Based Cervical Cancer Screening: Insights from WHO Recommendations

The WHO recommendations for HPV DNA-based cervical cancer screening emphasize a risk-based approach, recognizing that different carcinogenic HPV (cHPV) genotypes carry different levels of cervical cancer risk.

WHO highlights the importance of identifying key carcinogenic HPV genotypes for more informed clinical management, including:
HPV16
HPV18, HPV45
HPV31, HPV33, HPV35, HPV52, HPV58
HPV39, HPV51, HPV56, HPV59

In settings with sufficient follow-up capacity and treatment resources, WHO supports extended HPV genotyping strategies to enable more precise risk stratification:
✔ Higher-risk HPV genotypes such as HPV16, HPV18, HPV45, HPV31, HPV33, HPV35, HPV52 and HPV58 may support more direct clinical management pathways.
✔ Other carcinogenic HPV genotypes, including HPV39, HPV51, HPV56 and HPV59, may require additional triage evaluation.

By providing more detailed genotype information, extended HPV genotyping helps support evidence-based cervical cancer screening strategies.

What does this mean for laboratories?
As screening programs move toward more genotype-guided management, laboratories require flexible HPV testing solutions that support different clinical workflows.

Cowingene provides HPV molecular diagnostic solutions across NATBox Molecular POCT and Real-Time PCR platforms, covering different testing needs from routine HPV detection to extended genotyping and broader HPV characterization.

Explore Cowingene HPV solutions for your cervical cancer screening workflow.

🧬 Reliable Extraction. Flexible Workflow.

Every reliable molecular result starts with high-quality nucleic acid extraction. That's why Cowingene developed the NATPure System—an automated extraction platform designed to simplify laboratory workflows while delivering consistent, high-quality DNA/RNA for downstream molecular testing.

Powered by advanced magnetic bead technology, NATPure combines automation with flexibility. Available in 16- and 32-sample configurations, it allows laboratories to choose the throughput that best fits their testing needs. With an open reagent system, programmable protocols, and compatibility with a wide range of clinical sample types, NATPure easily adapts to different laboratory workflows and applications.

To complete the extraction workflow, the Cowingene DNA/RNA Extraction Kit is designed for seamless integration with the NATPure System, making routine extraction more efficient and convenient.

The kit is available in two formats to support different testing scenarios:

🧪 Multi-Test Format – Pre-filled reagent plates with 16 tests per plate, ideal for routine batch processing and improved laboratory efficiency.

🧪 Single-Test Format – Individual reagent strips that allow laboratories to use only the number of tests required, helping optimize reagent utilization while maintaining the same reliable extraction performance.

With ready-to-use pre-filled reagents, broad sample compatibility, and high-quality purified nucleic acids suitable for PCR,qPCR, NGS, and other molecular applications, the NATPure System and DNA/RNA Extraction Kit work together as a complete extraction solution—bringing efficiency, flexibility, and confidence to every workflow.